Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in.
Fosamax litigation ready for next step in bellwether cases
Six years after the first Fosamax lawsuit was filed, litigation over the osteoporosis drug is about to start a new chapter. The suits against Merck, the drug’s manufacturer, fall into two categories: plaintiffs alleging they suffer from osteonecrosis, or jaw damage, and those claiming they suffered a non-traumatic femur fracture as a result of taking the drug.